PRESS RELEASE published on 01/23/2026 at 11:00, 9 months 17 days ago Informations privilégiées / Autres communiqués GeNeuro SA demande la suspension temporaire de la cotation de ses actions sur Euronext Paris en attente de l'annonce du jugement du Tribunal de Genève sur son sursis concordataire GeNeuro SA Suspension Temporaire Sursis Concordataire Tribunal De Genève Cotation Actions
PRESS RELEASE published on 01/23/2026 at 11:00, 9 months 17 days ago Inside Information / Other news releases GeNeuro SA requests temporary suspension of trading on Euronext Paris pending Geneva Court judgment on debt moratorium. Details on debt restructuring and impact on operations Euronext Paris GeNeuro SA Swiss Law Temporary Suspension Debt Moratorium
BRIEF published on 10/15/2025 at 20:30, 1 year ago GeNeuro retarde la publication de son rapport financier semestriel Biopharmaceutique Rapport Financier Restructuration GeNeuro Moratoire Sur La Dette
BRIEF published on 10/15/2025 at 20:30, 1 year ago GeNeuro Delays Half-Year Financial Report Release Financial Report Restructuring Biopharmaceutical GeNeuro Debt Moratorium
PRESS RELEASE published on 10/15/2025 at 20:25, 1 year ago Inside Information / Other news releases GeNeuro SA postpones the publication of June 30, 2025 half-yearly financial report to assess financial impacts of debt-restructuring moratorium extension. New date to be announced Financial Report Postponement Neurological Disorders GeNeuro SA Debt-restructuring Moratorium
PRESS RELEASE published on 10/15/2025 at 20:25, 1 year ago Informations privilégiées / Autres communiqués GeNeuro SA annonce le report de la publication de son rapport semestriel au 30 juin 2025 suite à la restructuration en cours et à la prolongation de la procédure de sursis. La nouvelle date sera communiquée ultérieurement Restructuration Report GeNeuro SA Rapport Semestriel Sursis Concordataire
BRIEF published on 09/26/2025 at 18:41, 1 year 1 month ago GeNeuro SA : Prolongation du sursis concordataire jusqu'en 2026 Restructuration GeNeuro Sursis Concordataire Tribunal De Genève Maladies Neuros
BRIEF published on 09/26/2025 at 18:41, 1 year 1 month ago GeNeuro SA: Extension of the debt restructuring stay until 2026 Restructuring GeNeuro Neurological Diseases Composition Stay Geneva Court
PRESS RELEASE published on 09/26/2025 at 18:36, 1 year 1 month ago Inside Information / Other news releases GeNeuro SA extends its definitive debt-restructuring moratorium until January 27, 2026, to explore strategic options and continue developing treatments for neurodegenerative and autoimmune diseases Autoimmune Diseases GeNeuro SA Neurodegenerative Diseases Debt-restructuring Moratorium
PRESS RELEASE published on 09/26/2025 at 18:36, 1 year 1 month ago Informations privilégiées / Autres communiqués GeNeuro SA annonce la prolongation de son sursis concordataire définitif jusqu'au 27 janvier 2026, sous la supervision du Tribunal de Genève. Efforts de restructuration en cours pour maximiser la valeur Restructuration GeNeuro SA Maladies Neurodégénératives Auto-immunes Sursis Concordataire
Published on 11/10/2026 at 08:00, 1 hour 25 minutes ago PEL 82 - QatarEnergy to Acquire 25% Participating Interest from Chevron
Published on 11/10/2026 at 02:45, 6 hours 40 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 10 hours 15 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 10 hours 25 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 10 hours 53 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/10/2026 at 09:15, 10 minutes ago AssureTrace Appoints Graham Clark as Business Director and Chief Revenue Officer
Published on 11/10/2026 at 09:05, 20 minutes ago Cepheid Achieves CE Marking Under IVDR for Xpert® Respiratory Panel
Published on 11/10/2026 at 09:05, 20 minutes ago Jackery Black Friday 2026: Up to 58% Off Explorer v2 Portable Power Stations and Solar Generators, Starting at Just £378
Published on 11/10/2026 at 07:00, 2 hours 25 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 2 hours 25 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 14 hours 55 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 14 hours 55 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
